Industry News
Mesoblast shares up following FDA tick for phase II trials
The US Food and Drug Administration has given the go-ahead for Mesoblast (ASX:MSB) to conduct phase II trials of its stem cell treatment for Type 2 diabetes. [ + ]
Nominations for PM’s Prizes for Science open
The Prime Minister’s Prizes for Science are now open for nomination, including the $50,000 Science Minister’s Prize for Life Scientist of the Year. [ + ]
Last chance to take part in AusBiotech’s annual CEO survey
With the annual CEO Industry Position Survey 2012 closing this week, AusBiotech urges industry leaders to take this opportunity to contribute to the research, enabling an updated and comprehensive view of the Australian biotechnology sector. [ + ]
Cosmo Bio appoints Australian distributor
Cosmo Bio has appointed United Bioresearch as its Australian distributor. [ + ]
Waters recognises Thomson MS Laboratory as Center of Innovation
Waters Corporation has recognised the Thomson Mass Spectrometry Laboratory at the University of Campinas (UNICAMP), Brazil, as a Waters Center of Innovation. [ + ]
Australian-French partnership team up for drug development
The Monash Institute of Pharmaceutical Sciences and France's Servier have entered a three-year partnership for drug development research into G Protein-Coupled Receptors. [ + ]
Pumping iron raises prospect Parkinson’s and Alzheimer's treatment
Researchers have found a drug that removes excess iron from the brain can prevent Parkinson’s and Alzheimer's disease in mice, raising the prospect of a new treatment. [ + ]
A promise to a dying friend turns to a quest for a cure
It began with a promise to a dying friend and became a dedicated quest for a cure for cancer ... and a fundraiser to help. [ + ]
Xenome raises soothing $8m for pain treatment trial
Brisbane-based biopharma Xenome Limited has secured $8m in funding from its major investors to pay for a clinical trial of a synthetic peptide as a pain inhibitor. [ + ]
Australian nuclear security ranked best in the world
Australia has the best nuclear materials security practices in the world according to the Nuclear Materials Security Index - a report released by the Nuclear Threat Initiative. [ + ]
New skin cancer detection tool approved in Australia
Canada's Verisante Technology has been cleared by the TGA to sell its instant skin cancer detection tool in Australia. [ + ]
Biosceptre seeks $15m for anti-cancer monoclonal antibody trials
Funds sought to take monoclonal antibody treatment for multiple cancers into phase I trials on the lead up to IND submission with the US Food and Drug Administration. [ + ]
Epigenetic markers point towards ovarian cancer diagnostic
The discovery of new epigenetic markers present in a majority of ovarian cancers could lead to improved early diagnosis of the deadly disease. [ + ]
BioProspect tightens its focus
After suffering two costly delays, BioProspect (ASX:BPO) is refocusing on gaining local regulatory approval for its lead animal health product. [ + ]
Method for determination of crotamiton
Thermo Fisher Scientific has developed an efficient quality control method for the determination of the cis and trans isomers that comprise crotamiton, used in the treatment of scabies and skin pruritus. The method is more efficient than the official protocols of the British Pharmacopoeia (BP) and Pharmacopeia of the People’s Republic of China (PPRC). [ + ]
